Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
Qingqing Yin,1,2 Xiaojuan Ji,3 Renjun Lv,1 Jin-Jing Pei,4 Yifeng Du,5 Chao Shen,1 Xunyao Hou1 1Department of Geriatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People’s Republic of China; 2Department of Geriatric Neur...
Guardado en:
Autores principales: | Yin Q, Ji X, Lv R, Pei JJ, Du Y, Shen C, Hou X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29cd5ce80323466a80ff32b254f693af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current and emerging biomarkers of frailty in the elderly
por: Al Saedi A, et al.
Publicado: (2019) -
A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
por: Wei H, et al.
Publicado: (2019) -
Osteoimmune Modulation and Guided Osteogenesis Promoted by Barrier Membranes Incorporated with S-Nitrosoglutathione (GSNO) and Mesenchymal Stem Cell-Derived Exosomes
por: Wang X, et al.
Publicado: (2020) -
Topical Application of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells in Combination with Sponge Spicules for Treatment of Photoaging
por: Zhang K, et al.
Publicado: (2020) -
Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova B, et al.
Publicado: (2015)